BT

Brain Tumor Investment Fund

North America, Massachusetts, United States, Newton

Description

Brain Tumour Investment Fund (BTIF) is to make aid contributions to assist the growth of bi

Investor Profile

Brain Tumor Investment Fund has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (67%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Brain Tumor Investment Fund frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Varia Ventures
North America, New York, United States, Buffalo
Co-Investments: 1
Thiel Capital
North America, California, United States, Los Angeles
Co-Investments: 1
Tachyon Ventures
North America, California, United States, Los Angeles
Co-Investments: 1
MEDA Angels
North America, District of Columbia, United States, Washington
Co-Investments: 1
SF
North America, Florida, United States, Ponte Vedra Beach
Co-Investments: 2
Bioverge
North America, California, United States, San Francisco
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Brain Tumor Investment Fund?

EnClear Therapies

Cambridge, Massachusetts, United States

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

BiotechnologyTherapeutics
Series UnknownSep 3, 2024
MimiVax

Buffalo, New York, United States

MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.

BiopharmaBiotechnologyPharmaceutical
Series UnknownJan 9, 2024
KIYATEC

Greenville, South Carolina, United States

KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies.

BiotechnologyHealth DiagnosticsLife Science
Series CMay 18, 2023
Amount Raised: $18,000,000